Leslie Montgomery
Family · Whitney, TXNPI 1003405945
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 184 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations.
Across 184 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$424
- Lilly USA, LLC$317
- Novo Nordisk$242
- Harmony Biosciences LLC$211
- AstraZeneca$194
- GSK$160
- plus $2K from 28 others
What the payments were for
- Food & beverage$3,248100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $424 |
| Lilly USA, LLC | 19 | $317 |
| Novo Nordisk | 16 | $242 |
| Harmony Biosciences LLC | 7 | $211 |
| AstraZeneca | 8 | $194 |
| GSK | 9 | $160 |
| Boehringer Ingelheim | 10 | $159 |
| Exact Sciences | 8 | $159 |
| Otsuka America Pharmaceutical, Inc. | 7 | $134 |
| Axsome Therapeutics, Inc. | 6 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $92 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $90 |
| Amgen | 5 | $83 |
| Merck | 4 | $71 |
| Bayer | 5 | $71 |
| Dexcom, Inc. | 5 | $68 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $61 |
| Amarin Pharma, Inc. | 3 | $60 |
| Idorsia Pharmaceuticals US Inc | 3 | $59 |
| Corium, LLC | 2 | $59 |
| Novartis | 3 | $57 |
| Verona Pharma, Inc. | 2 | $49 |
| Kowa Pharmaceuticals America, Inc. | 2 | $45 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $42 |
| Pfizer | 2 | $34 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Ironshore Pharmaceuticals Inc. | 1 | $24 |
| Biogen | 1 | $23 |
| Vertex | 1 | $20 |
| Radius Health, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $16 |
| Corcept Therapeutics | 1 | $15 |
| Optinose US, Inc. | 1 | $15 |
How this compares
$3,248 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Other family in Whitney
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.